Summary
The effects of imipramine and desipramine were each examined at three dose levels in normal males. A placebo-controlled, double-blind procedure was employed. Effects were measured in a variety of behavioral and subjective responses. The resulting drug-action profiles reveal that imipramine produced hypnotic-like actions, as evidenced by the observation — and subjective reports — of marked sleepiness and concomitant impairment of intelectual and visuo-motor functioning. Side-effects of a cardiovascular, gastrointestinal disturbing, or anticholinergiclike nature were often experienced.
In contrast, desipramine produced effects in only two of the areas measured — a slight increase in sleepiness and a rise in pulse rate. The increased sleepiness was not accompanied by self-reports of a generalized impairment of performance, nor by actual decrements in performance measures. The side-effects reported were few in number and minimal in degree.
For both drugs the effects were dose related, maximal 2 1/2 hours after ingestion, and had subsided within 7 hours. The relationship of these effects to chemostructural variations, to clinical applications, and to possible modes of action of the two drugs were discussed.
Similar content being viewed by others
References
Ban, T. A., and H. E. Lehmann: Clinical trial with desmethylimipramine, a new antidepressant compound. Canad. med. Ass. J. 86, 1030–1031 (1962).
Brodie, B., P. Dick, P. Kielholz, W. Poldinger, and W. Theobald: Preliminary pharmacological and clinical results with desmethylimipramine, a metabolite of imipramine. Psychopharmacologia (Berl.) 2, 467–474 (1961).
Denber, H. C. B.: Chlorpromazine-diethazine in the treatment of depression. Dis. nerv. Syst. (Monograph Suppl.) 18 (7), 1–4 (1957).
Dimascio, A., L. Havens, and G. Klerman: The psychopharmacology of phenothiazine compounds: A comparative study of the effects of chlorpromazine, promethazine, trifluoperazine, and perphenazine in normal males. J. nerv. ment. Dis. 136 (1), 15–28; 136 (2), 168–186 (1963)
Domenjoz, R., u. W. Theobald: Zur Pharmakologie des Tofranil (N-(3-Dimethylaminopropyl)-iminodibenzylhydrochlorid). Arch. int. Pharmacodyn. 120, 450–489 (1959).
Flach, F. F., and P. F. Regan: Chemotherapy in emotional disorders. New York: McGraw-Hill Book Co. 1960.
Frommel, E., C. Fleury, et J. Schmidt-Genzkey: De l'action psychoanaleptique du Tofranil. Schweiz. med. Wschr. 90, 830 (1960).
Hill, R. T., I. Koosis, M. W. Minor, and E. B. Sigg: The potentiation of methylphenidate by imipramine, amitriptyline and their desmethyl analogues. Pharmacologist 3, 75 (1961).
Hollister, L. E., J. E. Overall, J. Shelton, M. Johnson, G. Katz, and V. Pennington: Controlled study of desipramine in depression. J. New Drugs (in press).
Lehmann, H. E., C. H. Cahn, and R. L. DeVerteuil: The treatment of depressive conditions with imipramine. Canad. psychiat. Ass. J. 3 (4), 155–164 (1958).
Mann, A.: Desmethylimipramine in the treatment of depression: Pilot study in a general hospital and outpatient setting. Canad. med. Ass. J. 86, 495–598 (1962).
Meduna, L. J., L. G. Abood, and J. H. Brel: (N(-Methylaminopropyl) Iminodibenzyl: A new antidepressant. J. Neuropsychiat. 2, 232–237 (1961).
Oltman, J. E., and S. Friedman: Preliminary investigation of desmethylimipramine. Amer. J. Psychiat. 119 (4), 370–371 (1962).
Pletscher, A., u. K. F. Gey: Pharmakologische Beeinflussung des 5-Hydroxytryptamine-Stoffwechsels im Gehirn und Monoaminoxydasehemmung in vitro. Helv. physiol. pharmacol. Acta 17, C 35 (1959).
Poldinger, W.: Comparison between imipramine and desipramine in normal subjects and their actions in depressive patients. Psychopharmacologia (Berl.) 4, 302–307 (1963).
Pollack, B.: Clinical findings in the use of Tofranil in depressives and other psychiatric states. Amer. J. Psychiat. 116, 312 (1959).
Pulver, R., B. Exer u. B. Herrmann: Einige Wirkungen des N-(Dimethylaminopropyl)-iminodibenzyl-HCL und seiner Metabolite auf den Stoffwechsel von Neurohormonen. Arzneimittel-Forsch. 10, 530–533 (1960).
Schaeppi, U.: Die Beeinflussung der Reizübertragung im peripheren Sympathicus durch Tofranil. Helv. physiol. pharmacol. Acta 18, 545–562 (1960).
Sigg, E. B.: Pharmacological studies with Tofranil. Canad. Psychiat. Ass. J. 4, 75–83 (1959), Special Suppl.
Stein, L., and J. Seifter: Possible model of antidepressive action of imipramine. Science 134 (3474), 286–287 (1961).
Sulser, F., J. Watts, and B. B. Brodie: On the mechanism of antidepressant action of imipramine-like drugs. Ann. N.Y. Acad. Sci. 96, 279–288 (1962).
Author information
Authors and Affiliations
Additional information
This study was supported by a grant from Lakeside Laboratories, Milwaukee, Wisconsin and in part by USPHS Grant MY-6304.
Rights and permissions
About this article
Cite this article
Di Mascio, A., Heninger, G. & Klerman, G.L. Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males. Psychopharmacologia 5, 361–371 (1964). https://doi.org/10.1007/BF00441447
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00441447